Zobrazeno 1 - 10
of 12
pro vyhledávání: '"D H, Biesma"'
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Idiopathic pulmonary fibrosis (IPF) often has significant diagnostic delay. At present it is not well-known what factors associate with time to diagnosis and if this is associated with survival after the diagnosis. There has also
Externí odkaz:
https://doaj.org/article/b9e5c742afbd4ca391695cf006a5754c
Autor:
K. Daniels, P. B. van der Nat, S. T. F. M. Frequin, P. J. van der Wees, D. H. Biesma, E. L. J. Hoogervorst, E. M. W. van de Garde
Publikováno v:
Multiple Sclerosis International, Vol 2020 (2020)
Background. Recently, ocrelizumab (Ocrevus®) was approved for the treatment of primary progressive multiple sclerosis (PPMS) based on data from the ORATORIO clinical trial. Real-world data about the clinical effectiveness of ocrelizumab has yet to b
Externí odkaz:
https://doaj.org/article/c5c8379ab12e4ff4bc0e7d42722a542f
Publikováno v:
Lung. 199(6)
Idiopathic pulmonary fibrosis (IPF) is a severe fibrotic lung disease, in which inflammation is thought to only play a secondary role. Several factors associated with acute exacerbations of IPF (AE-IPF) have been identified, including infections. Thi
Autor:
Timo F W, Soeterik, H H E, van Melick, L M, Dijksman, D H, Biesma, J A, Witjes, J P A, van Basten
Publikováno v:
Urology. 147:211-212
Autor:
D H, Biesma
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 162
The introduction of 'value' as a goal in healthcare requires a change of thinking. Quality becomes a leading principle. Transparency will lead to better care in hospitals that compare their results with each other. Making quality visible together cre
Autor:
M E R, Van Meegeren, K, Van Veghel, P, De Kleijn, P M, Van Roermund, D H, Biesma, F P J G, Lafeber, G, Roosendaal
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 18(5)
The incidence of haemophilic arthropathy in multiple joints decreased due to treatment with clotting factor. Nowadays patients are enabled to live a rather normal life, resulting in more (sports) trauma-induced arthropathy in isolated joints like the
Autor:
D E, Fransen van de Putte, K, Fischer, R J, de Knegt, D, Posthouwer, K J, van Erpecum, D H, Biesma, E P, Mauser-Bunschoten
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 18(3)
Hepatitis C infection is a major comorbidity in patients with inherited bleeding disorders. Successful antiviral treatment leads to a reduction in liver fibrosis, as shown by liver biopsies. Liver stiffness measurement (LSM) is a non-invasive method
Autor:
I E M, Den Uijl, E P, Mauser Bunschoten, G, Roosendaal, R E G, Schutgens, D H, Biesma, D E, Grobbee, K, Fischer
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 17(6)
The classification of haemophilia originates from 1950s and has been adopted unchallengedly by the ISTH in 2001. The aim of this study was: does the current classification compare onset of bleeding and age at first treatment, as well as annual joint
Autor:
R E, Schutgens, D H, Biesma
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 147(36)
Serial compression ultrasonography of the leg is a safe but inefficient method of diagnosing deep venous thrombosis (DVT). The introduction of the clinical score and the D-dimer test heralds a change in the diagnostics of DVT. It is now safe to withh
Autor:
C M, Segeren, P, Sonneveld, B, van der Holt, J W, Baars, D H, Biesma, J J, Cornellissen, A J, Croockewit, A W, Dekker, W E, Fibbe, B, Löwenberg, M, van Marwijk Kooy, M H, van Oers, D J, Richel, H C, Schouten, E, Vellenga, G E, Verhoef, P W, Wijermans, S, Wittebol, H M, Lokhorst
Publikováno v:
British journal of haematology. 105(1)
We examined the feasibility of achieving a rapid response in patients with previously untreated multiple myeloma by administering vincristine 0.4 mg and doxorubicin 9 mg/m2 as a rapid intravenous infusion for 4 d together with intermittent high-dose